All stock lists
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.69-0.19 (-10.11%)
Insider Score
––Not scored
BDTX Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
BDTX Stock Insider Trading Activity
BDTX stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Raman Prakash Director | Award | 6,801 | $1.93 | $13.13K | 15.1% | 51,840 | Sep 18, 2026 | — | Form 4 |
| Behbahani Ali Director | Award | 7,707 | $1.93 | $14.87K | 7.5% | 110,236 | Sep 18, 2026 | — | Form 4 |
| Behbahani Ali Director | Award | 8,961 | $1.66 | $14.88K | 9.6% | 102,529 | Jun 19, 2026 | — | Form 4 |
| Raman Prakash Director | Award | 7,907 | $1.66 | $13.13K | 21.3% | 45,039 | Jun 19, 2026 | — | Form 4 |
| Behbahani Ali Director | Award | 6,919 | $2.15 | $14.88K | 8.0% | 93,568 | Mar 20, 2026 | — | Form 4 |
| Raman Prakash Director | Award | 6,105 | $2.15 | $13.13K | 19.7% | 37,132 | Mar 20, 2026 | — | Form 4 |
| Behbahani Ali Director | Award | 5,208 | $2.76 | $14.37K | 6.4% | 86,649 | Dec 12, 2025 | — | Form 4 |
| Raman Prakash Director | Award | 4,665 | $2.76 | $12.88K | 17.7% | 31,027 | Dec 12, 2025 | — | Form 4 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.